Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.

Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, Bombardier C, Carmona L, van der Heijde D, Bijlsma JW, Boumpas DT, Canhao H, Edwards CJ, Hamuryudan V, Kvien TK, Leeb BF, Martín-Mola EM, Mielants H, Müller-Ladner U, Murphy G, Østergaard M, Pereira IA, Ramos-Remus C, Valentini G, Zochling J, Dougados M.

Ann Rheum Dis. 2009 Jul;68(7):1086-93. doi: 10.1136/ard.2008.094474. Epub 2008 Nov 25.

2.

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.

Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, Paulus HE, Mudano A, Pisu M, Elkins-Melton M, Outman R, Allison JJ, Suarez Almazor M, Bridges SL Jr, Chatham WW, Hochberg M, MacLean C, Mikuls T, Moreland LW, O'Dell J, Turkiewicz AM, Furst DE; American College of Rheumatology.

Arthritis Rheum. 2008 Jun 15;59(6):762-84. doi: 10.1002/art.23721. No abstract available.

3.

Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.

van der Heijde D, Klareskog L, Landewé R, Bruyn GA, Cantagrel A, Durez P, Herrero-Beaumont G, Molad Y, Codreanu C, Valentini G, Zahora R, Pedersen R, MacPeek D, Wajdula J, Fatenejad S.

Arthritis Rheum. 2007 Dec;56(12):3928-39.

4.
5.

Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis.

Tilling L, Townsend S, David J.

Clin Drug Investig. 2006;26(2):55-62.

PMID:
17163236
6.
7.

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, Emery P, Ferraccioli G, Hazes JM, Klareskog L, Machold K, Martin-Mola E, Nielsen H, Silman A, Smolen J, Yazici H.

Ann Rheum Dis. 2007 Jan;66(1):34-45. Epub 2006 Jan 5.

8.

Light and electron microscopic analysis of liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy.

Ros S, Juanola X, Condom E, Cañas C, Riera J, Guardiola J, Del Blanco J, Rebasa P, Valverde J, Roig-Escofet O.

Scand J Rheumatol. 2002;31(6):330-6.

PMID:
12492247
9.
10.
11.

A 36 month comparative trial of methotrexate and gold sodium thiomalate in the treatment of early active and erosive rheumatoid arthritis.

Menninger H, Herborn G, Sander O, Blechschmidt J, Rau R.

Br J Rheumatol. 1998 Oct;37(10):1060-8.

PMID:
9825744
12.

Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study.

Baecklund E, Ekbom A, Sparén P, Feltelius N, Klareskog L.

BMJ. 1998 Jul 18;317(7152):180-1. No abstract available.

13.

Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy.

Weinblatt ME, Maier AL, Fraser PA, Coblyn JS.

J Rheumatol. 1998 Feb;25(2):238-42.

PMID:
9489813
14.

Long-term treatment of destructive rheumatoid arthritis with methotrexate.

Rau R, Schleusser B, Herborn G, Karger T.

J Rheumatol. 1997 Oct;24(10):1881-9.

PMID:
9330927
16.

Quantitative liver function in patients with rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study.

Beyeler C, Reichen J, Thomann SR, Lauterburg BH, Gerber NJ.

Br J Rheumatol. 1997 Mar;36(3):338-44.

PMID:
9133966
17.

Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis.

Gutierrez-Ureña S, Molina JF, García CO, Cuéllar ML, Espinoza LR.

Arthritis Rheum. 1996 Feb;39(2):272-6.

PMID:
8849378
18.
19.

Long-term tolerability of methotrexate at doses exceeding 15 mg per week in rheumatoid arthritis.

Schnabel A, Herlyn K, Burchardi C, Reinhold-Keller E, Gross WL.

Rheumatol Int. 1996;15(5):195-200.

PMID:
8717103
20.

The relative toxicity of disease-modifying antirheumatic drugs.

Fries JF, Williams CA, Ramey D, Bloch DA.

Arthritis Rheum. 1993 Mar;36(3):297-306.

PMID:
8452574

Supplemental Content

Support Center